RSS | Print | PDF | Email Page

Blogs

Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, PTAB Litigation Blog

May 2017


Visit the Jones Day PTAB Litigation.

In Novartis AG v. Torrent Pharms. Ltd. (2016-1352), the Federal Circuit affirmed the PTAB’s decision in consolidated IPR proceedings (IPR2014-00784, IPR2015-00518) invalidating all claims of U.S. Patent 8,324,283. In doing so, the court affirmed the PTAB’s finding that Novartis’ evidence on the objective indicia of nonobviousness lacked sufficient nexus to the claimed invention to warrant a different outcome.

Read the full article at ptablitigationblog.com.

Author(s)

Areas of Concentration

Region/Jurisdiction


United States